Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 29,205 shares (grant or award)
  2. 4 Grant or award Director acquired 29,205 shares (grant or award)
  3. 4 Grant or award Director acquired 29,205 shares (grant or award)
  4. 4 Grant or award Director acquired 29,205 shares (grant or award)
  5. 4 Grant or award Director acquired 29,205 shares (grant or award)
  6. 4 Grant or award Director acquired 29,205 shares (grant or award)
  7. 4 Grant or award Director acquired 29,205 shares (grant or award)
  8. 4 Grant or award Director acquired 29,205 shares (grant or award)
  9. 4 Grant or award Director acquired 848 shares (grant or award)
  10. 4 Grant or award Director acquired 4,110 shares (grant or award)
  11. 4 Grant or award Director acquired 7,716 shares (grant or award)
  12. 4 Grant or award Director acquired 3,684 shares (grant or award)
  13. 4 Grant or award Director acquired 3,642 shares (grant or award)
  14. 4/A Open-market sale EVP, General Counsel sold 1,275 shares at an average $9.27 ($11,824)
  15. 4 Shares withheld for taxes EVP, General Counsel gave up 11,069 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 27,607 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 4,001 shares (to pay taxes)
  18. 4 Grant or award SVP, Controller & CAO acquired 25,266 shares (grant or award)
  19. 4 Open-market sale EVP, General Counsel sold 292 shares at $9.32 ($2,721)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 6,327 shares (to pay taxes)

Page 8 of 61 · 1,214 filings